Anlon Healthcare Limited board of directors approved a proposal to raise funds through the issuance of convertible warrants on a preferential basis. The aggregate amount for this capital raise will not exceed ₹250 crore.

The board meeting, held on October 13, 2026, authorized the issuance of warrants fully convertible into equivalent equity shares with a face value of ₹2 each. This move is in accordance with Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws.

Investor Details and Structure

The preferential issue is open to both promoters and non-promoter public investors. The board identified four specific allottees for this tranche:

• Punitkumar Rameshbhai Rasadia (Promoter)
• Meet Atulkumar Vachhani (Promoter)
• Smart Horizon Capital Advisors Private Limited (Public)
• Ploutos Plus Consultant Private Limited (Public)

The total number of warrants, their price, and the date for the shareholders' meeting will be determined in a subsequent board meeting. The issue will be undertaken for cash consideration.

Key Terms of the Issue

Payment and Conversion Mechanism

The structure of the warrants includes specific payment milestones. A minimum of 25% of the consideration must be paid on the date of allotment. The remaining 75% is payable at the time of allotment of equity shares when the option to convert is exercised.

If an allottee fails to exercise the conversion option within 18 months from the date of warrant allotment, or within any other period permitted under SEBI regulations, the consideration amount paid shall stand forfeited by the company. The resulting equity shares will be pari passu with existing fully paid-up equity shares.

What the Numbers Show

The disclosure highlights a concentrated investor base for this capital infusion, with only four named entities participating in the ₹250 crore raise. Notably, two of these investors are promoters, indicating significant internal participation alongside external public investors. The pricing mechanism remains deferred, with the exact price of warrants to be fixed later, suggesting flexibility in valuation based on market conditions at the time of final allotment.

Anlon Healthcare shares flagged a large-trade signal on the NSE, with approximately 6,870,493 shares changing hands at ₹29.90 per share, for a combined value of ₹20.54 crore.

This is a real-time large-trade signal, not a confirmed block or bulk deal. NSE/BSE publish official block and bulk deal reports only after market close — this trade may or may not appear there.

Large-trade signal details

The following table summarises the key parameters of the flagged activity:

The signal reflects a cluster of trades in Anlon Healthcare shares printed within a short window at or near ₹29.90, flagged by a real-time trade-scanning system for size and speed. The activity has not been confirmed or reported by the exchange as an official event.

No buyer, seller, broker, or client identity is known at this stage. Such information, if applicable, would only become available through the exchange's own post-market disclosures.

What this is, and isn't

What this is, and isn't: this reflects trade-level activity — a cluster of trades in the stock above, printed within a short window at or near the quoted price, for a combined value as stated. It is generated by our real-time trade-scanning system and is not, by itself, evidence of a block or bulk deal.

A block deal has to be executed in the exchange's dedicated window (8:45–9:00am or 2:05–2:20pm), within a set price band, and above the current minimum order size (₹25 crore). A bulk deal is when one client's total trading in a stock crosses 0.5% of its equity in a single day — confirmed only once every trade that client made is added up.

Both are published by NSE/BSE after trading hours end, typically after 3:30pm — never before. If this trade qualifies as either, it will appear in the exchange's own report later today, not here first.